18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

NCT05483023 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Drug cannot be produced and scanner down.

Conditions

Complex Atypical Hyperplasia
Endometrial Cancer

Interventions

DRUG: 18F-fluorofuranylnorprogesterone PET / MRI

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]